PE anti-human CD44 338807 from BioLegend

Product Specs
ItemPE anti-human CD44
CompanyBioLegend
Price Pricing Info Supplier Page View Company Product Page
Catalog Number338807
NCBI Gene AliasesCDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL, HUTCH-1, HUTCH-I, Hermes-1, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1
ApplicationsFlow Cytometry (FC)
Conjugate/TagPE
ReactivityHuman
HostMouse
IsotypeIgG1, Kappa
CloneBJ18
Quantity25 tests
Antibody TypePrimary
NCBI Full Gene NameCD44 molecule (Indian blood group)
FormatPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
ClonalityMonoclonal
ImmunogenNormal human PBL
TargetCD44

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) Derivation of Human Corneal Keratocytes from ReLEx SMILE Lenticules for Cell Therapy and Tissue EngineeringInternational Journal of Molecular SciencesMay 16, 2023Maria A. Surovtseva, Irina I. Kim, Natalia A. Bondarenko, Alexander P. Lykov, Kristina Yu. Krasner, Elena V. Chepeleva, Nataliya P. Bgatova, Alexander N. Trunov, Valery V. Chernykh, Olga V. PoveshchenkoCA, USA) using monoclonal antibodies to CD29 (100 µg/mL, cat. no. 303004), CD44 (50 µg/mL, cat. no. 338808), CD49a (200 µg/mL, cat. no. 328303), CD54 (100 µg/mL, cat. no. 353106) (all antibodies: Biolegend,

(2) Rapid and effective preparation of clonal bone marrow-derived mesenchymal stem/stromal cell sheets to reduce renal fibrosisScientific reportsMarch 17, 2023Kameishi S, Dunn CM, Oka M, Kim K, Cho YK, Song SU, Grainger DW, Okano T.CD73 + (BioLegend, 344014), CD90+ (BioLegend, 202507), CD105+ (BioLegend, 323208), CD44+ (BioLegend, 338808), CD34− (BioLegend, 343521), CD31− (BioLegend, 303110), CD45− (BioLegend, 304021) using flow cytometry

(3) Putative critical quality attribute matrix identifies mesenchymal stromal cells with potent immunomodulatory and angiogenic “fitness” ranges in response to culture process parametersFrontiers in ImmunologyNovember 30, 2022Kevin P. Robb, Julie Audet, Rajiv Gandhi, Sowmya ViswanathanBioLegend (San Diego, USA) were used: anti-CD90 (cat. 328109), anti-CD73 (cat. 344004), anti-CD44 (cat. 338807), anti-CD29 (cat. 303003), anti-CD13 (cat. 301703), anti-CD34 (cat. 343506), anti-CD31 (cat. 303105),

(4) Multifunctional profiling of triple-negative breast cancer patient-derived tumoroids for disease modelingSLAS discovery : advancing life sciences R & DApril 1, 2022Cromwell EF, Sirenko O, Nikolov E, Hammer M, Brock CK, Matossian MD, Alzoubi MS, Collins-Burow BM, Burow ME.

(5) Fatty acid β-oxidation promotes breast cancer stemness and metastasis via the miRNA-328-3p-CPT1A pathwayCancer gene therapyMarch 1, 2022Zeng F, Yao M, Wang Y, Zheng W, Liu S, Hou Z, Cheng X, Sun S, Li T, Zhao H, et al.106 cells/mL. Fixable Viability Dye eFluorTM 780 (Thermo, Cat#65-0865-14), Anti-CD44 (Biolegend, Cat#338807), Anti-CD24 (Biolegend, Cat#311103) were used protected from light. ALDEFLUOR kit (STEMCELL Technologies)

(6) Biglycan Promotes Cancer Stem Cell Properties, NFκB Signaling and Metastatic Potential in Breast Cancer CellsCancersJanuary 17, 2022Manupati K, Paul R, Hao M, Haas M, Bian ZC, Holm TM, Guan JL, Yeo SK.CD61-PE (Biolegend, 104308), CD24-FITC (Biolegend, 311104, San Diego, CA, USA), CD44-PE (Bioledgend, 338808) and Aldefluor assay kit (Stemcell Technologies, 01700, Vancouver, BC, Canada). 4.3. RNA Sequencing RNA-sequencing

(7) Hexokinase 2-driven glycolysis in pericytes activates their contractility leading to tumor blood vessel abnormalitiesNature communicationsOctober 14, 2021Meng YM, Jiang X, Zhao X, Meng Q, Wu S, Chen Y, Kong X, Qiu X, Su L, Huang C, et al.APC-conjugated anti-human CD13 (Biolegend, 301706, 1:300), or PE-conjugated anti-human CD44 (Biolegend, 338808, 1:100) was analyzed by performing flow cytometry. Immunohistochemistry and immunofluorescent staining Formalin-fixed, paraffin-embedded

(8) Association of human breast cancer CD44-/CD24- cells with delayed distant metastasiseLifeJuly 28, 2021Xinbo Qiao, Yixiao Zhang, Lisha Sun, Qingtian Ma, Jie Yang, Liping Ai, Jinqi Xue, Guanglei Chen, Hao Zhang, Ce Ji, et al.(FITC)-conjugated anti-CD24 (Cat. #311104; BioLegend, San Diego, CA, USA) and PE-conjugated anti-CD44 (Cat. #338808; BioLegend) antibodies. Control cells were stained with an isotype control, FITC-anti-CD24 or PE-anti-CD44

(9) Blocking TNFα attenuates progressive cartilage matrix degradation in inflammatory arthritisExperimental and Therapeutic MedicineMay 27, 2021Jinsung Park, Hyosun Park, Young Lim Lee, Subin Weon, Yong-Gil Kim, Jae-Hyuk Yang, Bora Nam, Sungsin Jo, Tae-Hwan Kim554715; BD Biosciences) and stained with CD34 (cat. no. 343607; BioLegend, Inc.; 1:100), CD44 (cat. no. 338807; BioLegend, Inc.; 1:100), CD59 (cat. no. 304711; BioLegend, Inc.; 1:100), CD74 (cat. no. 326811; BioLegend, Inc

(10) Tight Junction Protein Claudin-12 Is Involved in Cell Migration during MetastasisBiomoleculesApril 25, 2021Desislava Kolchakova, Dzhemal Moten, Tsvetelina Batsalova, Balik Dzhambazov(L-selectin) antibody (clone DREG-56, cat. No 304804), and anti-human CD44-PE antibody (clone BJ18, cat. No 338808), all produced in mouse, were purchased from BioLegend® (San Diego, CA, USA). Annexin V-FITC and propidium

(11) Efficacy of atovaquone on EpCAM⁺CD44⁺ HCT-116 human colon cancer stem cells under hypoxiaExperimental and therapeutic medicineDecember 1, 2020Fu C, Xiao X, Xu H, Lu W, Wang Y.anti-EpCAM antibody (1:20; cat. no. 324203) and phycoerythrin-conjugated anti-CD44 antibody (1:20; cat. no. 338807; both from BioLegend, Inc.) in the dark for 10 min at 4˚C. The cells were washed with PBS and then acquired

(12) Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 TherapyCellNovember 25, 2020Jiang L, Wang YJ, Zhao J, Uehara M, Hou Q, Kasinath V, Ichimura T, Banouni N, Dai L, Li X, et al.anti-CD8 (53–6.7, #553031, BD PharMingen), APC anti-CD3 (17A2, #100236, Biolegend), PE anti-CD44 (BJ18, #338808, Biolegend), FITC anti-CD80 (16-10A1, #104706, Biolegend), PerCP/Cy5.5 anti-CD86 (GL-1, #105026, Biolegend),

(13) CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcomaNature chemical biologyJanuary 1, 2020Ross NT, Lohmann F, Carbonneau S, Fazal A, Weihofen WA, Gleim S, Salcius M, Sigoillot F, Henault M, Carl SH, et al.buffer (PBS, with 1% BSA) and stained with either PE-conjugated CD73 (BioLegend 344004), CD44 (BioLegend 338808), CD54 (BioLegend 353106), or CD11b (BioLegend 301306). Samples were processed on a LSR Fortessa cell

(14) TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcriptionNature communicationsDecember 16, 2019Yu JM, Sun W, Wang ZH, Liang X, Hua F, Li K, Lv XX, Zhang XW, Liu YY, Yu JJ, et al.MCF7 cells cultured in serum-free medium were stained with phycoerythrin (PE)-conjugated anti-CD44 (1:400, 338808) and fluorescein isothiocyanate-conjugated anti-CD24 (1:100, 311108) antibodies (Biolegend). CD44BrCD24Di

(15) Influence of glucose and insulin in human adipogenic differentiation models with adipose-derived stem cellsAdipocyteDecember 1, 2019Kolodziej M, Strauss S, Lazaridis A, Bucan V, Kuhbier JW, Vogt PM, Könneker S.IM1431U,0,2,9,6,0,11,5 ± 1.9 CD 34,Beckmann Coulter; A21691,0,32,11,8,6,11,11 ± 4.5 CD 44,Biolegend; 338808,96,98,97,98,81,99,95 ± 2.8 CD 45,Beckmann Coulter; IM2652U,0,10,21,11,12,46,17 ± 6.5 CD 73,Biolegend;

(16) Inhibition of microRNA‑221‑5p induces osteogenic differentiation by directly targeting smad3 in myeloma bone disease mesenchymal stem cellsOncology LettersOctober 17, 2019Fang‑Yi Fan et al.100 µl PBS (1×106 cells) with 5 µl of the following antibodies: Mouse anti-human CD44-PE (cat. no. 338807; 1:20), CD90-FITC (cat. no. 328107; 1:20), CD105-PC5.5 (cat. no. 323215; 1:20), CD34-FITC (cat. no.

(17) Cancer stem-like cells with increased expression of NY-ESO-1 initiate breast cancer metastasisOncology lettersOctober 1, 2019Liu MY, Su H, Huang HL, Chen JQ.resuspended in serum-free medium to obtain a single-cell suspension. Anti-CD44-PE (1:100; cat. no. 338808) and anti-CD24-Percp/cy5.5 (1:100; cat. no. 311116), in addition to the isotype control antibodies for

(18) Human amnion mesenchymal stem cells attenuate atherosclerosis by modulating macrophage function to reduce immune responseInternational journal of molecular medicineOctober 1, 2019Wei X, Sun G, Zhao X, Wu Q, Chen L, Xu Y, Pang X, Qi G.

(19) Understanding the mechanism underlying the acquisition of radioresistance in human prostate cancer cellsOncology lettersJune 1, 2019Murata K, Saga R, Monzen S, Tsuruga E, Hasegawa K, Hosokawa Y.

(20) Human amniotic epithelial cells regulate osteoblast differentiation through the secretion of TGFβ1 and microRNA-34a-5pInternational journal of molecular medicineFebruary 1, 2018Wang G, Zhao F, Yang D, Wang J, Qiu L, Pang X.(5 μl per test in 100 μl PBS; all purchased from BioLegend, San Diego, CA, USA): Anti-CD44 (cat. no. 338807), anti-CD90 (cat. no. 32810), anti-CD105 (cat. no. 323205), anti-CD117 (cat. no. 313204), anti-SSEA-4

Write a Review

(1)

2/2/2016CD44 PE Antibody Review Michaela RekowMice are infected with virus. Spleens are collected, cells are RBC lysed, Fc blocked, stained, and washed before fixing and performing flow. We are looking at lymphocyte subpopulations.

eLife

Experimental and therapeutic medicine

Oncology letters

Experimental and therapeutic medicine

Oncology letters

PE anti-human CD44 from BioLegend

Description

BioLegend

Citations (26)

Reviews

PE anti-human CD44 from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map